Acquired coagulation disorders

Slides:



Advertisements
Similar presentations
Chapter 12 Disorders of Hemostasis
Advertisements

Hemorrhagic diseases. Lesions of the blood vessels Lesions of the blood vessels Abnormal platelets Abnormal platelets Abnormalities in the coagulation.
BLEEDING DISORDERS AN OVERVIEW WITH EMPHASIS ON EMERGENCIES.
Initiation substances activate s by proteolysis a cascade of circulating precursor proteins which leads to the generation of thrombin which in turn converts.
Bachelor of Chinese Medicine, The University of Hong Kong Bleeding disorders Dr. Edmond S. K. Ma Division of Haematology Department of Pathology The University.
Haemostasis Tiffany Shaw MBChB II Haemostasis Pathway Injury Collagen exposure Tissue Factor Platelet adhesion Coagulation Cascade Release reaction.
Vascular Pharmacology
MLAB 1227: Coagulation Keri Brophy-Martinez
Vitamin K Vitamin K is a group of lipophilic, hydrophobic vitamins. They are needed for the postranslation modification of proteins required for blood.
RHY/CH00561 Biology of Disease CH0576 Hyperbilirubinaemia & Jaundice II.
Disseminated intravascular coagulation (DIC)
Dr msaiem Acquired Coagulation Disorders Dr Mohammed Saiem Al-dahr KAAU Faculty of Applied Medical Sciences.
Asilmi HEMOSTASIS Ahmad Shihada Silmi Faculty of Sciences IUG Med. Tech. Dep. Room # B326.
Dr MOHAMMED H SAIEMALDAHR FACULTY of Applied Medical Sciences
Lecture NO- 12- Dr: Dalia Kamal Eldien.  Coagulation: Is the process by which blood changes from a liquid to a clot. Coagulation begins after an injury.
A bleeding diathesis has been recognized in pt. with CCHD, a variety of coagulation abnormalities has been postulated: 1- Polycythemia 2- Hyper viscosity.
Hemostasis and Blood Coagulation
FUNCTIONS OF THE COAGULATION SYSTEM ACTIONDESIRED RESULT Rapid formation of mechanically sound clot Stop bleeding quickly Prevent clot formation at non-injured.
Vitamin K Dr.S.Chakravarty MD. Vitamin K: K1 – phylloquinone – plant source K2 – menaquinone – bacterial source K3 – Menadione – synthetic form.
Bleeding Disorders Dr. Farjah H.AlGahtani
Approach to Bleeding Disorders
1 HAEMOSTASIS. 2 Definition Haemostasis is a complex sequence of physical and biochemical changes induced by damage to tissues and blood vessels, which.
APPROACH TO BLEEDING DISORDERS. History of Bleeding Spontaneous vs. trauma/surgery-induced Ecchymoses without known trauma Medications or nutritional.
Haemostasis Presented by Dr Azza Serry. Learning Objectives  Definition.  Clotting mechanism.  What keeps blood in fluid status  Control of blood.
ACQUIRED COAGULATION ABNORMALITIES
MLAB 1227: Coagulation Keri Brophy-Martinez Coagulation Disorders: Secondary Hemostasis Part Two.
Coagulation Mechanisms
Disseminated Intravascular Coagulation. XIIa Coagulation cascade IIa Intrinsic system (surface contact ) XII XI XIa Tissue factor IX IXa VIIa VII VIIIVIIIa.
BLOOD Disorders.
Inherited bleeding disorder of primary hemostasis.
Hematology Blueprint PANCE Blueprint. Coagulation Disorders.
Biochemistry of Vitamin K GIT Block 1 Lecture. Overview Types and chemistry of vitamin K Sources and daily requirements Functions Synthesis of  -carboxyglutamate.
BLOOD DISORDERS.
HEMOSTASIS When blood vessels are cut or damaged, the loss of blood from the system must be stopped before shock and possible death occur. This is accomplished.
DIC. acute, subacute or chronic widespread intravascular fibrin formation in response to excessive blood protease activity that overcomes the natural.
1. Normal haemostasis Haemostasis is the process whereby haemorrhage following vascular injury is arrested. It depends on closely linked interaction.
Anticoagulants Course: Pharmacology I Course Code: PHR 213 Course Instructor: Sabiha Chowdhury Lecturer Department of Pharmacy BRAC University.
Chapter 23. Bleeding disorders associated with coagulopathy
Bleeding Tendency Dr. Mervat Khorshied Ass. Prof. of Clinical and Chemical Pathology.
Platelets. Fig Hemostasis the process by which the bleeding is stopped from broken vessels. steps involved: Vascular spasm. Platelets plug formation.
Obada Al-Eisa Saud Bashtawy Emad Mansour.  It is an acquired condition characterized by massive activation of the coagulation system.  It is always.
Haemostasis describes the normal process of blood clotting. It takes place via a series of complex, tightly regulated interactions involving cellular.
Bleeding disorders due to vascular & platelets abnormalities
Bleeding disorders Deficiency of any of the clotting factors leads to excessive bleeding Most common and important bleeding disorders are due Vitamin K.
Secondary Haemostasis
Factors against intravascular clotting]
Blood Disorders.
Chapter 18 Disorders of Hemostasis
Immune thrombocytopenia purpura(ITP)
These factors prevent blood clotting - in normal state.
Haemostasis An efficient Mechanism is functional to maintain the circulation as a transport system. It prevents blood loss from damaged vessels. It also.
Thrombosis.
Lec. 12….
General Approach of Haemostasis
General Approach in Investigation of Hemostasis
Biochemistry of Vitamin K
Diagnosis Approach of Bleeding in Children ________________________________ Ketut Ariawati Hematologi Onkologi RSUP Sanglah Denpasar.
Constituents of the blood: Platelets and plasma
Dr. Nasim AP Biochemistry
Vitamin K deficiency Domina Petric, MD.
The Hematologic System as a Marker of Organ Dysfunction in Sepsis
Intra vascular anti-coagulants
Disseminated intravascular coagulation (DIC) + Thrombotic microangiopathies (TTP+HUS) Ali Al Khader, M.D. Faculty of Medicine Al-Balqa’ Applied University.
VITAMIN-K. VITAMIN-K Different forms of Vitamin K Vitamin K1 (phylloquinon) – plant origin Vitamin K2 (menaquinon) – normally produced by bacteria.
Drugs Affecting Blood.
Principles of Coagulation Screening II
THROMBOSIS.
Dr. Ahmed Hassaneen Coagulation disorders.
Presentation transcript:

Acquired coagulation disorders

Acquired coagulation disorders: They are more common than the inherited disorders. Unlike the inherited disorders, multiple clotting factor deficiencies are usual.

The acquired coagulation disorders The acquired coagulation disorders. Deficiency of vitamin K-dependant factors Haemorrhagic disease of the newborn Biliary obstruction Malabsorption of vitamin K(e.g. tropical sprue, gluten induced enteropathy) Vitamin K-antagonist therapy (e.g. coumarins, indandiones) Liver disease Disseminated intravascular coagulation Inhibition of coagtulation Specific inhibitors (e.g. antibodies against factor VIII) Non-specific inhibitors (e.g. antibodies found in systemic lupus erythematosus, rheumatoid arthritis) Miscellalleous Diseases with M-protein production L-Asparaginase Therapy with heparin, defibrinating agents or thrombolytics Massive transfusion syndrome

Vitamin K deficiency in children or adults Caused by : obstructive jaundice pancreatic small bowel disease inadequate diet malabsorption drugs as warfarin which act as vit.K antagonists is associated with decrease in functional activity of factors : II, VII,IX, X & protein C & S ,but the immunological methods show normal levels of these factors.

Haemorrhagic disease of the newborn Vitamin K-dependent factors are low at birth and fall further in breast-fed infants in the first few days of life. Liver cell immaturity, lack of gut bacterial synthesis of the vitamin and low quantities in breast milk may all contribute to a deficiency which may cause haemorrhage, usually on the second to fourth day of life, but occasionally during the first 2 months

liver disease Multiple haemostatic abnormalities contribute to a bleeding tendency and may exacerbate haemorrhage from oesophageal varices, 1 Biliary obstruction results in impaired absorption of vitamin K and therefore decreased synthesis of factors II, VII, IX and X. 2 With severe hepatocellular disease, in addition to a deficiency of these factors, there are often reduced levels of factor V and fibrinogen and increased amounts of plasminogen activator

3 Functional abnormality of fibrinogen (dysfibrinogenaemia) 4 Decreased thrombopoietin production from the liver contributes to thrombocytopenia. 5 Hypersplenism associated with portal hypertension frequently results in thrombocytopenia. 6 Disseminated intravascular coagulation

Haemostasis tests in Acquired coagulation disorders

DIC (disseminated intravascular coagulation). Wide spread intravascular deposition of fibrin with consumption of coagulation factors & platelets occur as consequence of many disorders which release procoagulant material into the circulation or cause wide spread endothelial damage or platelets aggregation. It may be associated with fulminant hemorrhagic syndrome or run less severe & more chronic course.

Coagulation deficiency caused by antibodies Circulating antibodies to coagulation factors are occasionally seen with an incidence of approximately1 per millon per year. Alloantibodies to factor VIII occur in 5-10% of haemophiliacs. Factor VIII autoantibodies may also result in a bleeding syndrome. These immunoglobulin G (IgG) antibodies occur rarely post-partum, in certain immunolological disorders (e.g. rheumatoid arthritis), in cancer and in old age. Treatment usually consists of a combination of immunosuppression and treatment with factor replacement

Massive transfusion syndrome Many factors may contribute to a bleeding disorder following massive transfusion, Blood loss results in reduced levels of platelets, coagulation factors and inhibitors, Further dilution of these factors occurs during replacement with red cells,